Business and Finance Business and Finance
Fri, December 7, 2012
Thu, December 6, 2012

DSM Completes Acquisition of Cargill's Cultures and Enzymes Business


Published on 2012-12-06 09:45:38 - Market Wire
  Print publication without navigation


December 06, 2012 12:27 ET

DSM Completes Acquisition of Cargill's Cultures and Enzymes Business

HEERLEN, NETHERLANDS--(Marketwire - Dec 6, 2012) - Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it has successfully completed the acquisition of Cargill's cultures and enzymes business. The acquisition, announced on 26 October 2012, will enable DSM to become a global tier one dairy ingredients supplier.

The cultures and enzymes business of Cargill is a global leading manufacturer of cultures and enzymes for the dairy and meat industries with manufacturing operations in Wisconsin (USA) and France. It has a strong pipeline of new products built on three pillars of technology: culture texture toolbox, fast acidification for cheese yield improvements and culture flavor systems. The business generates net sales of about EUR45 million per year with approximately 200 employees.

The market for cultures and enzymes is valued at over EUR1 billion, growing steadily at more than 5% per annum. Applications are primarily found in dairy products which continue to have a healthy and tasty appeal to consumers worldwide. The growing diversity of dairy products requires versatile culture offerings enhancing taste, texture and mouth feel characteristics as well as health benefits (lower fat, less sugar, etc.) and convenience.

By combining Cargill's cultures and enzymes business with the dairy business of DSM Food Specialties, a strong global player will be created, enabling DSM to accelerate sales and capture meaningful synergies in global manufacturing and customer reach as well as innovation capabilities in biotechnology and SG&A.

The combination of the two businesses will allow DSM to achieve its ambition to become a tier one supplier of cultures and enzymes to the global dairy market and will greatly accelerate DSM's growth plans for its business, which continues to benefit from strong consumer demand for more versatile dairy products. The acquisition further strengthens DSM's global position in dairy ingredients with enzymes, PUFAs, vitamins, cultures, probiotics, bio actives, preservation systems and tests.

DSM - Bright Science. Brighter Living.™ Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of around EUR9 billion. The company is listed on NYSE Euronext. More information can be found at [ www.dsm.com ]. For more information:




Press Release-pdf: [ http://hugin.info/130663/R/1663111/539273.pdf ]

 This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. 

Source: DSM N.V. via Thomson Reuters ONE

[HUG#1663111]


Contributing Sources